Emmingen – Rudolf Storz GmbH continues to grow: The contract manufacturer for medical technology, which belongs to the Stuckenbrock Group and has over 170 employees, has acquired an additional building directly opposite its current headquarter in the Hundsrücken industrial park. With around 6,000 m² of additional space, the company is not only expanding its premises, but also significantly increasing its production capacity, sending a clear signal for sustainable growth and future viability.
Rudolf Storz has already invested continuously in the expansion of its existing location in recent years. Just last year, another company building with 1,200 m² was constructed, which now serves as a modern sales and logistics center. Due to continued growth, this is currently being expanded with an extension to create additional space for further high-bay warehouses in the future.
In recent weeks, the Stuckenbrock Group has also been able to purchase the company premises formerly used by the insolvent mahe medical GmbH, including the buildings erected on it, from the owner family. With the acquisition of the property directly opposite its current headquarter, the Stuckenbrock Group is consistently continuing the further development of the site.
“With the new building, we are laying the foundation for further healthy growth and investing specifically in a modern, efficient, and future-oriented manufacturing infrastructure,” explains managing partner Fabian Stuckenbrock. The additional building not only offers space for additional production facilities and the expansion of the product range, but also for the introduction of modern, innovative production technologies that meet the high quality requirements of medical technology.
The expansion increases the production area to a total of approximately 11,500 m². The machine park is also being expanded: In addition to the company building, the Stuckenbrock Group acquired around 50 machines from the assets of the now insolvent mahe medical GmbH. “The business operations of mahe medical GmbH were already discontinued months ago, long before the insolvency proceedings were opened. It was therefore only possible to purchase various assets from the insolvency estate,” explains Stuckenbrock.
“Demand for our services is growing steadily worldwide, and our customers’ product portfolios are also expanding,” adds Marius Buchta, Sales Manager at Rudolf Storz. “This investment will enable us to remain true to our usual quality standards and meet our customers’ requirements. At the same time, we are demonstrating our determination to continue investing in our performance capabilities.”
The Emmingen site is also benefiting from the expansion: new jobs are being created and additional value is being added to the region. “Of course, the location is very important to me,” emphasizes Stuckenbrock. “We have a great region with reliable customers and partners in the immediate vicinity. It’s worth producing here. This enables us to ensure the highest level of quality and delivery reliability.”
With this investment, Rudolf Storz is responding to rising market demand and consolidating its position as a reliable contract manufacturer in the international medical technology industry.
